Merck (MRK) Raw Materials (2009 - 2012)

Merck (MRK) reported Raw Materials of $265.0 million for Q2 2012, down 11.07% year-over-year from $298.0 million in Q3 2011, and down 14.52% quarter-over-quarter from $310.0 million in Q1 2012.

Merck (MRK) Raw Materials (2009 - 2012) Analysis & Trends

Merck (MRK) has 4 years of Raw Materials data on file, last reported at $265.0 million in Q2 2012.

  • Raw Materials for Q2 2012 came in at $265.0 million, down 11.07% year-over-year; the trailing twelve-month figure through Jun 2012 was $265.0 million (down 11.07% YoY), and the FY2011 annual result was $297.0 million, down 5.71% from the prior year.
  • Raw Materials slipped to $265.0 million in Q2 2012 per MRK's latest filing, from $310.0 million in the prior quarter.
  • Over five years, Raw Materials peaked at $5.8 billion in Q3 2011 and troughed at $265.0 million in Q2 2012.
  • A 4-year average of $1.4 billion and a median of $312.5 million in 2010 frame the typical range for Raw Materials.
  • On a YoY basis, Raw Materials climbed as much as 1694.0% in 2011 and fell as far as 94.39% in 2011.
  • A 4-year view of Raw Materials shows it stood at $323.0 million in 2009, then slipped by 2.48% to $315.0 million in 2010, then dropped by 5.71% to $297.0 million in 2011, then dropped by 10.77% to $265.0 million in 2012.
  • Business Quant data shows MRK's Raw Materials at $265.0 million in Q2 2012, $310.0 million in Q1 2012, and $297.0 million in Q4 2011.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Gsk 92,134,969.93 Bn 92,134,964.97 Bn 7.76 Bn
2 Eli Lilly 1,027.45 Bn 1,022.17 Bn 16.22 Bn
3 Johnson & Johnson 559.08 Bn 537.03 Bn 15.96 Bn
4 AbbVie 394.75 Bn 385.40 Bn 10.78 Bn
5 Merck 295.12 Bn 289.47 Bn 12.09 Bn
6 Amgen 186.65 Bn 174.61 Bn 5.87 Bn
7 Gilead Sciences 159.22 Bn 151.50 Bn 5.52 Bn
8 Pfizer 146.00 Bn 133.23 Bn -1.21 Bn
9 Bristol Myers Squibb 113.22 Bn 102.77 Bn 8.07 Bn
10 Novartis Ag 108.02 Bn 107.33 Bn -

Historic Data

Download Data
DateValue
Jun 30, 2012 265.00 Mn
Mar 31, 2012 310.00 Mn
Dec 31, 2011 297.00 Mn
Sep 30, 2011 5.80 Bn
Jun 30, 2011 298.00 Mn
Mar 31, 2011 306.00 Mn
Dec 31, 2010 315.00 Mn
Sep 30, 2010 323.30 Mn
Jun 30, 2010 5.31 Bn
Dec 31, 2009 323.00 Mn